AH
Asad Haider Goldman Sachs Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
NewAmsterdam Pharma
NAMS
$2.89B
| $25.66 | $27 |
5%
upside
| Neutral | 1 month ago |
|
2
BioNTech
BNTX
$24.9B
| $103.50 | $110 |
6%
upside
| Neutral | 3 months ago |
|
3
Johnson & Johnson
JNJ
$431B
| $178.76 | $172 |
4%
downside
| Buy | 4 months ago |
|
4
Eli Lilly
LLY
$666B
| $742.91 | $888 |
20%
upside
| Buy | 4 months ago |
|
5
AbbVie
ABBV
$376B
| $213 | $194 |
9%
downside
| Neutral | 4 months ago |
|
6
Bristol-Myers Squibb
BMY
$95B
| $46.69 | $55 |
18%
upside
| Neutral | 4 months ago |
|
7
Pfizer
PFE
$140B
| $24.54 | $25 |
2%
upside
| Neutral | 4 months ago |
|